Technology area: Semiconductors, Circuits & Optics
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Optilab LLC has 2 pending office actions in the Semiconductors, Circuits & Optics technology area. Both of these 2 pending office actions are located within 1 distinct art unit, showing a high level of technical concentration for the company's current filings. The company is working with 2 distinct examiners to resolve these matters, meaning each action is being reviewed by a different individual despite being in the same art unit. The concentration in 1 distinct art unit suggests a specific technological focus for the company's current innovation.
SMITH, MAURICE C is the busiest examiner, with 1 pending office action. In this small portfolio, each of the 2 distinct examiners handles exactly one case. The concentration in 1 distinct art unit means that while the examiners are different, they are both working within the same technical classification. This may allow for some consistency in the technical arguments used across the 2 pending office actions. Practitioners should look for commonalities in how the 1 distinct art unit handles semiconductor and optics cases to optimize their approach. The 2 pending office actions allow for a highly detailed focus on each matter.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SMITH, MAURICE C | 1 | 84.6% | -4.2% |
| REVERMAN, CHAD ANDREW | 1 | 58.7% | +41.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19454004 | THIN-FILM LITHIUM-NIOBATE (TFLN)-BASED MODULATOR FOR FIBER OPTIC GYROSCOPES AND OTHER APPLICATIONS | SMITH, MAURICE C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18741501 | OPTICALLY ISOLATED LIGHTWAVE CURRENT SENSOR | REVERMAN, CHAD ANDREW | 5d overdue |
| Art Unit | Apps |
|---|---|
| 2877 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19454004 | THIN-FILM LITHIUM-NIOBATE (TFLN)-BASED MODULATOR FOR FIBER OPTIC GYROSCOPES AND OTHER APPLICATIONS | SMITH, MAURICE C | 2877 | §102§103 | Final Rejection | — | Pending | Jan 20, 2026 |
| 18741501 | OPTICALLY ISOLATED LIGHTWAVE CURRENT SENSOR | REVERMAN, CHAD ANDREW | 2877 | §103 | Final Rejection | 5d overdue | Pending | Jun 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOptilab LLC has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Maurice C Smith has the most, with 1 of Optilab LLC's pending office actions.
Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.